NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...
AiCuris Anti-infective Cures AG today announced the initiation of its Phase 1, first-in-human trial of AIC468, a novel antisense oligonucleotide. AIC468 is an antiviral agent which aims to treat BK ...
Look in your cabinets for some potential cold sore relief—and possibly ways to prevent future breakouts, too The post 12 Cold ...
The breakthrough treatment uses cutting-edge DNA sequencing that may help millions of people ... A new therapeutic virus, RP1, has been created from the herpes simplex virus, which causes cold sores.